Disclosure Of Entity's Operating Segments [Text Block]

Pharming Group N.V. - Filing #5829944

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of entity's operating segments [text block]		—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	297,200,000 USD	—	—	—	—	—	—	245,316,000 USD	—	—	—	—
Tax expense (income)	3,349,000 USD	—	—	—	—	—	—	1,464,000 USD	—	—	—	—
Profit (loss) before tax	8,492,000 USD	—	—	—	—	—	—	12,012,000 USD	—	—	—	—
Profit (loss)	11,841,000 USD	— USD	— USD	—	— USD	11,841,000 USD	— USD	10,548,000 USD	—	— USD	10,548,000 USD	— USD
Assets	—	—	—	399,985,000 USD	—	—	—	—	462,854,000 USD	—	—	—
Investments accounted for using equity method	—	—	—	466,000 USD	—	—	—	—	2,285,000 USD	—	—	—
Cash flows from (used in) operating activities	1,795,000 USD	—	—	—	—	—	—	17,302,000 USD	—	—	—	—
Cash flows from (used in) investing activities	31,618,000 USD	—	—	—	—	—	—	129,388,000 USD	—	—	—	—
Cash flows from (used in) financing activities	34,412,000 USD	—	—	—	—	—	—	1,039,000 USD	—	—	—	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]